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INTRODUCTION
Because of differences in radiosensitivity between laboratory animals and humans for the induction of specific types of cancers, results obtained from animal experiments are not used directly to obtain quantitative estimates of cancer risks for human populations. 1) However, animal studies are generally recognized to be valuable for clarifying the biological and physical factors that influence radiation responses. We carried out a series of experiments to elucidate the age-dependence of susceptibility for the late effects of radiation, and showed that mice aged between the early post-natal and puberty periods are most susceptible to lifeshortening and induction of various neoplasms by radiation. [2] [3] [4] We also examined the dose-response relationships for life-shortening, death rate, attributable death and incidences of neoplastic diseases in mice irradiated neonatally with gamma rays. [5] [6] Maisin et al. (1996) reported a surprising observation that male C57BL mice irradiated with 0.5 Gy X rays at 7 days of age survived longer than the control. 7) However, distinct life-shortening and an increase in the incidences of neoplasms were detected in female B6C3F 1 mice irradiated with 0.48 Gy gamma rays at day 0 of age in our previous studies. [5] [6] In the large-scale experiments conducted at Oak Ridge National Laboratory using the female RFM strain of mice in the young adult period, the life-shortening and carcinogenic effects were also evident at the dose level of 0.5 Gy gamma rays. [8] [9] [10] One of the purposes of the present experiment is to examine whether the life-elongation effect of gamma-irradiation at 7 days of age can be detectable.
The main purpose of the present study is to obtain the magnitude of the attributable death after irradiation at 7 days of age with 0.1 Gy gamma rays in comparison with that after irradiation with 0.48 or 0.95 Gy at the same age. This experiment was designed and conducted because the following findings suggest that it may be meaningfull as a basis of risk estimation to obtain the magnitude of the attributable death in mice irradiated with doses ranging from 0.1 to 0.95 Gy gamma rays during the infant period: 1) Carnes et al. showed that the magnitude of the increase in the death rate from all causes after irradiation with a specific dose of radiation was almost similar among mice, dogs and humans, when the time scale was adjusted for species differences in the life span. [11] [12] They mentioned that the successful interspecies extrapolation of age-specific mortality risks enhances both the value of studies involving laboratory animals and the potential relevance of the animal studies to the prediction of health effects in humans.
2) The effect of 137 Cs gamma-irradiation on the overall and tumor-specific death rate was examined by Prentice et al. with a proportional-hazards regression technique using data from a large study of RFM mice. 13) They showed that the relative risk for overall death rate was significantly different from 1 even in mice irradiated with 0.1 Gy gamma rays.
3) Sasaki and Fukuda improved the method for exact analysis of the late effects of radiation, and showed doseresponse relationship and age-dependence of susceptibility for the late effects of radiation. 4, 6) These studies demonstrated that the persistent increase in the death rate from all causes and from solid tumors is important and reliable endpoint of the late effects of radiation. 4) Experimental studies using laboratory animals have the advantage that the influence of confounding factors can be eliminated, although the sample size of animal studies is generally smaller than that of epidemiological studies.
In this experiment, mice irradiated with 0.10, 0.48 or 0.95 Gy gamma rays at 7 days of age were allowed to live out their entire life span under a specific pathogen-free condition together with a simultaneously ongoing control group.
MATERIALS AND METHODS

Experimental protocol
The present experiment was conducted according to legal regulations in Japan and following the Guidelines for Animal Experiments of the National Institute of Radiological Sciences. The first-generation hybrid mice between C57BL/6JNrs and C3H/HeNrs strains (B6C3F 1 ) were used in this study. The parent mice were bred in the SPF Animal Facility and were transferred to the Experimental Carcinogenesis Facility of the Institute at 8 weeks of age. Hybrid mice were irradiated at 7 days of age with 0.10, 0.48 or 0.95 Gy gamma rays from 137 Cs at a dose rate of 0.80 Gy per minute. Gamma-irradiation was always performed at 2-4 PM. The offsprings were weaned at 28-30 days of age and number of survivors at weaning was defined as the effective number for calculation of mean life span and incidences of neoplastic diseases. Female hybrid mice were served in the lifetime study, and males were used in the short-term experiments of which results are not included in the present report. As shown in Table 1 , Numbers of mice in the 0.10, 0.48 and 0.95 Gy groups of the lifetime study were 1388, 283 and 205, respectively. A simultaneously ongoing control group was set up, in which the number of animals was 1003. Three to five mice were housed in aluminum cages with a bedding of hardwood chips, and cages were periodically rotated through cage racks. Mice were fed pellet diet and allowed to drink chlorinated water (pH 2-3). Animal rooms were maintained at a temperature of 22-24 degrees C, 45-55 percent humidity and a 12-h light/dark cycle. Cages were checked for dead mice once a day (6 days/week). All mice in the lifetime study were allowed to live out their entire life span under a specific pathogen-free (SPF) condition. Sentinel mice were killed periodically and pathological, microbial and serological examinations for infectious diseases were performed by the constituents of the Section of Laboratory Animals of the Institute. There were no results which indicated breaks in the integrity of the SPF barrier.
Mean life span and death rate from all causes
The statistical difference between the mean life span in irradiated groups and that in the control group was examined with Student's t test. The death rate from all causes was represented as the number of deaths per 10,000 mouse-day at risk. The standard error of the death rate was obtained on the assumption that the number of deaths during a specific age interval has a binomial distribution.
Incidences of neoplastic diseases, number of types of solid tumors and death rate from solid tumors
After natural deaths of mice, gross and histopathological examinations were performed. The number of types of solid tumors per mouse at death was obtained as a sensitive measure of radiation-related carcinogenesis. For example, when three hepatocellular tumors and two ovarian tumors were found in a mouse, the number of types of solid tumors was counted as two. Incidences of various types of neoplastic diseases were calculated, the primary cause of death of each mouse was assessed and death rates from solid tumors were calculated. Differences in the number of types of solid tumors per mouse were examined with Student's t test, and difference in tumor incidence was analyzed with the Χ 2 test or Fisher's direct probability method.
Excess relative risk for death rate
As an exact measure of the late effects of radiation, the excess relative risk (ERR) for death rate was used. The Excess relative risk was calculated for the death rate from all causes, solid tumors and specific types of neoplasms. method of analysis was essentially the same as that used in the previous studies. 4, 6) Number of excess deaths, D(ex), and number of background deaths, D(bg), in irradiated groups were estimated with the following equations: 
The attributable death fraction (ADF) was defined as the ratio of the excess death fraction (EDF) to the observed death fraction (ODF): ADF = EDF/ODF. The attributable death fractions can be calculated for specific types of neoplasms, for all solid tumors and for all causes of death. Because the observed death fraction for all causes of death is 1, the attributable death fraction is equivalent to the excess death fraction.
Dose-response relationship
As shown in previous reports, [5] [6] the dose-response relationship for mean life span in female B6C3F 1 mice irradiated neonatally with gamma rays ranging from 0 to 5. 
where α represents coefficient of the linear function. Dose-response relationship of the relative risk for death rate from all causes in female B6C3F 1 mice irradiated neonatally with gamma rays ranging from 0 to 2.85 Gy was adequately fitted by following exponential model: RR(D) = exp(0.0044D), where RR(D) and D represent relative risk for death rate from all causes and dose of gamma rays in Gy, respectively. 6) Since the dose range was narrow in the present experiment, following linear model was fitted to the dose-response relationship of relative risk for death rate from all causes: RR(D) = 1 + β D, where β represents coefficient of the linear function. Because ERR(D)is RR(D)-1, the dose-response relationship of ERR for death rate from all causes used in the present study can be described as follows:
Dose-response relationship of ERR for death rate from solid tumors was also fitted to the linear model. The coefficients of dose-response relationships were obtained with regression analysis, in which the algorithm was the damping Gauss-Newton method.
All P values in the present report are based on two-sided statistical tests.
RESULTS
Life-shortening
The sample size and temporal variation of the survival (%) are shown in Table 1 . A distinct decrease in the survival at the specific age was observed after irradiation with 0.95 or 0.48 Gy gamma rays. A slight decrease in the survival percentage was detected in mice irradiated with 0.10 Gy. The means and standard errors of the life span in the control and irradiated groups are also summarized in Table 1 . The mean life span of mice irradiated with 0.10 Gy was 857.3 days, which was significantly shorter than that of the control group (P = 0.0308). Shortening of the mean life span was 1.58%. The mean life span and shortening in mice irradiated with 0.48 Gy were 817.0 days and 6.21%, and those in the 0.95 Gy group were 782.1 days and 10.22%. Dose-response relationship for the mean life span fitted adequately to following equation (P = 0.849):
Standard error of the coefficient was 0.0056.
Death rate from all causes
Temporal variations in the death rate from all causes in the control and irradiated groups are presented in Table 2 . After irradiation with 0.95 Gy, statistically significant increase in the death rate (P < 0.05) was detected in mice at age 651-750 days and older. In the group irradiated with 0.48 Gy, the death rate increased significantly in mice at age 751-850 days and older. When mice were irradiated with 0.10 Gy, statistically significant increase in the death rate was detected at 951-1050 days of age (P < 0.01). A tendency of increasing death rate was observed at 651-750 and 751-850 days of age in mice irradiated with 0.10 Gy, but the increase was not statistically significant (P > 0.05). The death rates at 1051-1150 and 1151-1250 days of age in the 0.10 Gy group were almost similar to those in the control group.
The attributable death fractions (ADF) and excess relative risks (ERR) are also shown in Table 2 . ADF in mice irradiated with 0.10 Gy was 0.092, which implies that 9.2% of deaths were attributable to radiation exposure. Because the standard error was 0.033, the estimated value of ADF was significantly different from zero (P < 0.01). The attributable death fraction in the 0.48 Gy group was 0.411, and that in the 0.95 Gy group was 0.547. The excess relative risks for death rate from all causes in 0.10, 0.48 and 0.95 Gy groups Days of life lost ( ± SE) 13.8 ± 6.2 54.1 ± 8.5 89.0 ± 9.6
Shortening (% ± SE) 1.58 ± 0.72 6.21 ± 0.97 10.22 ± 1.10 ERR(D) = 1.304D.
Standard error of the coefficient was 0.045.
Number of types of solid tumors at death
The mean numbers of types of solid tumors observed at death in the control and irradiated groups are summarized in Table 3 . The mean number of types of solid tumors in the control group was 0.547 and the standard error was 0.021. In mice irradiated with 0.10 Gy, the mean number of types of solid tumors was 0.762 with a standard error of 0.021. Therefore, it can be concluded that the numbers of types of solid tumors increased significantly by irradiation with 0.10 Gy gamma rays (P < 0.0001). The distributions of numbers of types of solid tumors at the time of death and the mean numbers of types of solid tumors in mice which died at different ages are also summarized in Table 3 . These results clearly showed the tumorigenic effect of 0.10 Gy gamma rays delivered at 7 days of age. The mean number of solid tumors per mouse after irradiation with 0.48 or 0.95 Gy reached 1.353 and 1.260, respectively. The tendency of increasing mean numbers of types of solid tumors per mouse with increasing age at death was observed in all groups. Dose-dependent increases in numbers of types of solid tumors were found in wide range of ages.
Death rate from solid tumors
Temporal variations in the death rates in the irradiated groups and control group are summarized in Table 4 . The death rates during 451-550, 651-750, 751-850 and 951-1050 days of age in the 0.10 Gy group were significantly higher than those in the control group (P < 0.05). Increases in the death rate from solid tumors were not observed before 450 days in all irradiated groups examined. Increases in the death rate from solid tumors were apparently dosedependent. Excess relative risks for death rate from solid tumors in the irradiated groups are shown in Table 4 together with the observed, background, excess and attributable death fractions. The excess relative risk in the 0.10 Gy group reached a high value of 0.45, which was associated with a standard error of 0.09. The excess relative risk in 0.48 Gy group was 2.52, and that in 0.95 Gy group was 4.12. The mean ages at death from solid tumors in all irradiated groups were earlier than that in the control group, which suggested the dose-dependent acceleration of the development of solid tumors. The excess relative risks are plotted against dose in Fig. 1 . It is clearly shown that the relative risks for solid tumors were far larger than those for all causes. The Dose-response relationship for the excess relative risks for solid tumors fitted well to following 
Incidences of neoplastic diseases
Incidences of six types of neoplastic diseases are summarized in Table 5 , in which those of neoplasms recognised as the primary cause of death are shown separately. For fatal neoplastic diseases, the the excess relative risk for death rate are presented, because the excess relative risk is exact measureof effect of radiation exposure which can avoid confusion by competing risks. The mean ages at death from fatal neoplastic diseases are also shown in Table 5 .
Incidence of pituitary tumors in mice irradiated with 0.10 Gy was significantly higher than that in the control group (P < 0.01). A large part of the pituitary tumors was recognized as fatal. The excess relative risk in the 0.10 Gy group was 0.64 and the standard error was 0.22. The excess relative risks in the 0.48 and 0.95 group were 2.49 and 5.49, respectively. The excess relative risks in all irradiated groups were significantly different from zero (P < 0.01). The mean age at death from pituitary tumors in the 0.10 Gy group was significantly earlier than that in the control group (P < 0.05).
The mean age at death from the pituitary tumors became earlier with increasing dose. Ovarian tumors developed in excess with statistically significant difference after irradiation with 0.10 Gy gamma rays (P < 0.0001). The incidence of ovarian tumors and the standard error in the control group were 2.2% and 0.5%, respectively, and those in the 0.10 Gy group were 14.7% and 1.0%, respectively. Incidences of ovarian tumors irradiated with 0.48 Gy reached a high value of 41.7%. A further increase in dose did not result in a higher incidence, as the incidence of ovarian tumors in the 0.95 Gy group was 44.4%. The majority of ovarian tumors seemed to be non-fatal, but a fraction of them was recognised as the primary cause of death. The excess relative risk for death rate from the fatal ovarian tumors after irradiation with 0.10 Gy was estimated to be 9.38. But this estimate was accompanied by a large standard error.
Adrenal tumors developed at an incidence of 1.4% in mice irradiated with 0.10 Gy gamma rays. Because the background incidence was low (0.4%), the increase in incidence was statistically significant (P < 0.05). Incidences of adrenal tumors in the 0.48 and 0.95 Gy groups were not statistically different from that in the control group (P > 0.05), since sample sizes of these irradiated groups were not so large. The majority of adrenal tumors which developed in the irradiated groups were recognized to be fatal.
A marked increase in the incidence of liver tumors was found in mice irradiated with 0.48 and 0.95 Gy. Increase in the incidence of liver tumors was not observed in mice irradiated with 0.10 Gy gamma rays. The Incidences of fatal and all types of liver tumors in the 0.10 Gy group were lower than that in the control group (P < 0.05), but the excess relative risk for death rate from liver tumors was not different from zero (P > 0.10). These results showed that decrease in the observed incidence of liver tumors in 0.10 gy group was mainly attributable to competing risks. The mean age at death from fatal liver tumors in the 0.10 Gy group was not different from that in the control group. In mice irradiated with higher doses, mean ages at death from the liver tumors were earlier than in the control group depending on the dose of gamma rays. A significant increase in the incidence of all types of lung tumors was observed in mice irradiated with 0.10 Gy (P < 0.01), but the incidence of fatal lung tumors was not different from that in the control group (P > 0.10). The excess relative risk for death rate from lung tumors was not different from zero (P > 0.10) in 0.10 Gy group. In mice irradiated with 0.48 or 0.95 Gy, the incidences of fatal and all types of lung tumors were higher than those in the control group (P < 0.05), and excess relative risks for death rate from lung tumors were different from zero (P < 0.05). An earlier occurrence of fatal lung tumors was evident in mice irradiated with 0.48 or 0.95 Gy. The mean age at death from fatal lung tumors in the 0.10 Gy group was slightly earlier than that in the control group, although difference was not statistically significant (P > 0.10).
Malignant lymphoma of the histiocytic type occurred at a high incidence in the control group. The incidence of this neoplasm decreased significantly after irradiation with 0.48 or 0.95 Gy (P < 0.0001). A decrease in the incidence of malignant lymphoma of the histiocytic type was not observed in mice irradiated with 0.10 Gy gamma rays.
DISCUSSION
In previous studies, we examined the age-dependence of susceptibility to life-shortening effect of gamma rays using female B6C3F1 mice, and showed that mice aged between neonatal and puberty periods are highly susceptible. [2] [3] [4] As a result of the present study, it has become evident that lifeshortening effect can be detectable after irradiation with 0.10 Gy at day 7 postnatal age. Dose-response relationships of life-shortening and carcinogenic effects were analyzed mainly for mice irradiated at day 0 neonatal period. [5] [6] Therefore, we describe at first differences between responses after irradiation at day 7 and those at day 0. Life-shortening effects of 0.48 and 0.95 Gy gamma rays delivered at day 7 were larger than those after irradiation with same doses at day 0. As shown in the present study, the mean life span was 782.1 days in mice irradiated with 0.95 Gy at day 7 (Table  1) . When mice were irradiated with same dose at day 0, the mean life span was 807.9 days. 6) Difference in the mean life span is statistically significant (P < 0.05). The mean life spans were 817.0 and 842.0 days after irradiation with 0.48 Gy at day 7 and day 0, respectively. Difference is also statistically significant (P < 0.02). The mean life span in the control group of the present study (871.1 days) was not different from that of the previous study (864.8 days). Linear dose-response relationship fitted well to data on mean life spans after irradiation at day 0 with doses ranging from 0 to 2.85 Gy. [5] [6] As shown in the present study, linear doseresponse relationship fitted adequately to the mean life spans within dose range 0 to 0.95 Gy. However, shape of the doseresponse curve for mean life spans in mice irradiated at day 7 with doses ranging from 0 to 2.85 Gy seemed to be slightly concave upward, although results of analysis were not presented in a previous report. 14) We also examined the influence of age at irradiation on carcinogenic effect, and concluded that age-dependence of susceptibility to radiationinduced carcinogenesis is inherent to specific types of neoplasms. [2] [3] [4] The spectrum of neoplasms induced by irradiation at day 7 postnatal age was almost similar to that after irradiation at day 0, but some differences were observed in previous studies in which dose level was 1.9 or 3.8 Gy 2-4) as followings: (1) Hepatocellular tumors and ovarian tumors developed at high incidences after irradiation at day 0 and 7. (2) Incidences of thymic lymphomas and bone tumors were higher in mice irradiated at day 7. (3) Irradiation at day 0 was more effective to induce pituitary tumors. (4) Harderian gland tumors did not develop in excess after irradiation at day 0, whereas irradiation at day 7 was effective to induce this type of neoplasm. (5) Slight increases in incidences of lung, adrenal, gastro-intestinal, renal and splenic tumors were detected after irradiation at day 0 and 7.
The increase in number of types of solid tumors per mouse at the time of death was clearly detected even after irradiation with 0.10 Gy (Table 3 ). This result indicated that the infant mice are highly susceptible to solid tumor induction by ionizing radiation and that number of types of solid tumors per mouse is a comprehensive measure suitable for the analysis of the tumorigenic effect of low-dose radiation. However, exact analysis of the magnitude of the tumorigenic effect should be performed using the death rate from solid tumors as described here. The coefficient of the dose-response relationship for the excess relative risk for death rate from solid tumors was far larger than that from all causes (Fig. 1) . Mean ages at death from solid tumors in the irradiated groups were earlier than that in control group. These findings suggested that the increase in the death rate from solid tumors may be due to the development of solid tumors in excess and partly due to acceleration of the development of solid tumors. Incidences of pituitary, ovarian and adrenal tumors in mice irradiated with 0.10 Gy were significantly higher than those in the control group (Table 5) . Increases in the incidences of these neoplasms were found in a previous study in which mice were irradiated at day 0 of the neonatal period.
5) The present study confirmed the high susceptibility of these endocrine organs during the infant period to radiation-induced tumorigenesis.
Prentice et al. mentioned that the increase in the overall death rate is a reliable measure of the late effects of ionizing radiation in experimental studies, and they showed statistically significant increase in the overall death rate after irradiation with 0.10 Gy gamma rays in a large scale experiment using female RFM mice which was conducted at Oak Ridge National Laboratory. 13) In the present study, an increase in the overall death rate was also detected in female B6C3F1 mice irradiated with 0.10 Gy gamma rays. The magnitude of the excess relative risk was almost similar in both studies. The attributable death fraction reached a high value of 0.092. Maisin et al. (1996) 7) reported that male C57BL/Cnb mice exposed to 0.5 Gy 250 kVp X rays at 7 days of age lived significantly longer than controls. The present study showed evidently that irradiation at 7 days of age with 0.48 Gy gamma rays caused life-shortening in female B6C3F1 mice. In a previous study, reduction of the mean life span was also observed after irradiation with 0.48 Gy gamma rays at day 0 of the neonatal period in the same hybrid mice. [5] [6] Storer et al. 8) reported that RFM mice lived an average of 75 days less than controls when exposed to 0.5 Gy gamma rays. In the study of Maisin et al. life-shortening could not be detected even after irradiation with 1 Gy X rays. Reduction of the mean life span was distinct after exposure to 0.95 Gy gamma rays in the present experiment. Maisin et al. 7) stated that the life-shortening effect observed after 3 Gy X rays was about the same as those found in adult mice after 4 Gy gamma rays or 350 R X rays in their earlier study in which the experimental condition was not the same. 15) Based on these limited findings, they concluded that exposure during infancy does not shorten survival much more than the exposure of adults. However, the results of our studies do not support their conclusion, because it has been evidently shown that the infant mice were more susceptible to radiation-induced life-shortening than adult mice. [2] [3] [4] [16] [17] Lindop and Rotblat 18) clearly showed that mice of the infant and puberty periods are highly susceptible to life-shortening effect of ionizing radiation, although they did not present the age-dependence of susceptibility to induction of specic types of neoplastic diseases. Benjamin et al. showed that irradiation with 60 Co gamma rays during the perinatal period was more effective to induce neoplastic and non-neoplastic diseases than irradiation during the adult period in beagle dogs. [19] [20] Therefore, it is reasonable that children are recognized as a sensitive subpopulation in the recent risk assessment of radiation and chemical carcinogenesis. [21] [22] [23] [24] [25] [26] Cologne and Preston 27) calculated relative death rates and survival distribution using an internal comparison (cohortbased estimation of background death rate) for survivors of the atomic bombs in Hiroshima and Nagasaki, and suggested that life shortening in human beings is about 1-2% per Gy. On the other hand, in the UNSCEAR 1982 report 28) it was estimated that, for various strains of mice and rats, there is a 5% loss of life expectancy per Gy of acute X-ray or gamma-ray exposure. It is an important question whether humans are more resistant to radiation-induced life-shortening than laboratory animals. Carnes et al. 12) provided an estimate of the days lost per centigray that ranged from approximately half a day for the mouse to 2 days for the dog and 20 days for humans. Results of the analysis by Carnes et al. suggested that humans are not more resistant to radiation-induced life-shortening than laboratory animals. However, firm statements on the relative sensitivity of different species for the life-shortening effect of ionizing radiation must await further studies, because the majority of atomic bomb survivors exposed during childhood and young adult period are still alive. The age-dependence of susceptibility should be accounted for in the analysis of the life-shortening effect for both humans and laboratory animals.
In the last decade, new findings on the adverse health effects of ionizing radiation were obtained from epidemiological studies, as reviewed in recent reports. 1, [29] [30] [31] [32] These studies showed that human beings experienced exposure to ionizing radiation ranging from very low to high doses.
Some of these studies indicated the high susceptibility of children to radiation carcinogenesis. Because epidemiological investigations are confused by many confounding factors, the extent of the risk obtained from these studies is often accompanied with large uncertainties. In recent experimental studies, genetically engineered and tumor predisposed rodents are frequently used. [33] [34] [35] These genetically tumor predisposed rodents are very susceptible to the induction of specific types of neoplasms, and the use of tumor predisposed animals may improve knowledge on mechanisms of radiation carcinogenesis. However, genetically engineered and tumor predisposed animals display the narrow spectrum of neoplastic diseases. Correctly designed life span experiments using regular strains and hybrids of mice followed by the thorough analysis of obtained data may provide significant information to understand the characteristics of the late effects of ionizing radiation.
